Search

Your search keyword '"Anne-Christine, Bay-Jensen"' showing total 18 results

Search Constraints

Start Over You searched for: Author "Anne-Christine, Bay-Jensen" Remove constraint Author: "Anne-Christine, Bay-Jensen" Journal gastroenterology Remove constraint Journal: gastroenterology
18 results on '"Anne-Christine, Bay-Jensen"'

Search Results

2. Su1655: ENDOTROPHIN (PRO-C6) IS ASSOCIATED WITH MRE CONFIRMED INTESTINAL STRICTURES AND PROTEIN FINGERPRINT BIOMARKERS OF COLLAGEN DEGRADATION IS ASSOCIATED WITH ULCERATIONS IN PAEDIATRIC CROHN'S DISEASE PATIENTS – RESULTS FROM THE IMAGEKIDS STUDY

3. Mo1524: SEROLOGICAL BIOMARKERS OF TYPE VI AND XXII COLLAGEN FORMATION PREDICT AND MONITOR INFLIXIMAB TREATMENT RESPONSE IN PATIENTS WITH CROHN’S DISEASE

4. Mo1523: BIOMARKERS OF EXTRACELLULAR MATRIX TURNOVER AND NEUTROPHIL ACTIVITY PREDICT LONG-TERM RESPONSE TO VEDOLIZUMAB IN PATIENTS WITH CROHN’S DISEASE

5. Su1526: TYPE I COLLAGEN DEGRADATION FRAGMENTS (C1M) AND HUMAN NEUTROPHIL ELASTASE-DERIVED FRAGMENTS OF CALPROTECTIN (CPA9-HNE) REFLECT BIOCHEMICAL AND ENDOSCOPIC DISEASE ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

6. Sa460 NEO-EPITOPE PROTEIN FRAGMENT OF CALPROTECTIN DERIVED FROM HUMAN NEUTROPHIL ELASTASE (CPA9-HNE) IS A NOVEL SERUM CALPROTECTIN BIOMARKER OF INFLAMMATION AND DISEASE ACTIVITY FOR IBD

7. Fr206 NOVEL BLOOD-BASED BIOMARKERS FOR MONITORING DISEASE PROGRESSION IN ADULT EOSINOPHILIC ESOPHAGITIS PATIENTS

8. Su435 BIOMARKERS OF EXTRACELLULAR MATRIX REMODELING IDENTIFY RESPONDERS TO VEDOLIZUMAB THERAPY IN SUBJECTS WITH ULCERATIVE COLITIS IN THE GEMINI I STUDY

9. 581 A FIBROSIS RESOLUTION BIOMARKER: DETECTION OF PROTEASE DEGRADED, AND CROSS-LINKED TYPE III COLLAGEN DEGRADATION FRAGMENTS RELEASED FROM THE FIBROTIC ECM, BY A NEO-EPITOPE SPECIFIC BLOOD-BASED BIOMARKER IN LIVER FIBROSIS

11. Sa1174 - Serological Assessment of Wound Healing in Crohn's Disease

12. Sa1798 - Platelet Activation by Activated Von Willebrand Factor is a Marker of Intestinal Wound Healing in Patietns with Crohns Disease

13. Su1791 Degradation Fragments of the Extracellular Matrix Measured in Patients with Inflammatory Bowel Disease is Related to Differential Diagnosis and Ileocolonic Involvement in Crohn's Disease

15. Early Suppression of the Serological Macrophage Activity Biomarker VICM, and not Suppression of CRP, Predicts the Response to Infliximab in Crohn's Disease Patients

16. 189 MMP Degraded Type III Collagen Is a Novel Serological Biomarker for Penetrating (Montreal B3) Crohn's Disease

17. Su1185 Citrullinated and Matrix Metalloproteinase Degraded Vimentin (VICM) and Matrix Metalloproteinase Degraded Biglycan (BGM) Have High Diagnostic Accuracy to Differentiate Crohn's Disease From Ulcerative Colitis

Catalog

Books, media, physical & digital resources